Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/10/2005CA2564432A1 Human anti-amyloid .beta. peptide antibody and fragment of said antibody
11/10/2005CA2564368A1 Chemical compounds
11/10/2005CA2564303A1 Novel pyrrole derivatives with angiotensin ii antagonist activity
11/10/2005CA2564288A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidin-2-yl and 5, 6, 7, 8-tetrahydro-quinazolin-2-yl compounds
11/10/2005CA2564277A1 7h-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for production the active agent
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2564249A1 Indole and azaindole derivatives with antitumor action
11/10/2005CA2564175A1 Chemical compounds
11/10/2005CA2564134A1 Antifungal drug delivery
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2564085A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005CA2563990A1 Thienopyridazines as ikk inhibitors
11/10/2005CA2563982A1 Thienopyridines as ikk inhibitors
11/10/2005CA2563963A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
11/10/2005CA2563959A1 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
11/10/2005CA2563957A1 Low molecular weight polylactic acid polymers
11/10/2005CA2563918A1 2-methylthiazolidine-2,4-dicarboxylic acid containing combination preparations
11/10/2005CA2563830A1 Transdermal steroid formulation
11/10/2005CA2563810A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension
11/10/2005CA2563776A1 Processes for preparing montelukast sodium
11/10/2005CA2563760A1 Pharmaceutical compositions comprising glycopyrrolate
11/10/2005CA2563669A1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents
11/10/2005CA2563558A1 Sulfonamides
11/10/2005CA2563454A1 Crth2 receptor antagonists
11/10/2005CA2563443A1 Therapeutic formulations of desoxyepothilones
11/10/2005CA2563222A1 Novel imidazoles
11/10/2005CA2563161A1 Tri-substitued 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstited pyran derivatives
11/10/2005CA2563063A1 Purification of progesterone receptor modulators
11/10/2005CA2562919A1 Aqueous solutions comprising prednisolone and a cyclodextrin derivative
11/10/2005CA2562585A1 Dpi formulation containing sulfoalkyl ether cyclodextrin
11/10/2005CA2562400A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005CA2562379A1 Veterinary meloxicam formulations suitable for intramammary treatment ofinflammatory disorders in mammals
11/10/2005CA2562297A1 Administration of enoxaparin sodium to patients 75 years and older with st-segment elevation myocardial infarction
11/10/2005CA2562296A1 Management of breakthrough bleeding in extended hormonal contraceptive regimens
11/10/2005CA2562177A1 Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
11/10/2005CA2562164A1 Labeling of rapamycin using rapamycin-specific methylases
11/10/2005CA2562160A1 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
11/10/2005CA2560167A1 Statins for the treatment of ocular hypertension and glaucoma
11/10/2005CA2560165A1 Solid pharmaceutical form comprising an ltb4 antagonist
11/10/2005CA2555718A1 Naphthalimide derivatives for the treatment of cancer
11/10/2005CA2555461A1 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/10/2005CA2553721A1 Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
11/09/2005EP1593686A1 Antineoplastic peptides
11/09/2005EP1593684A1 Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof
11/09/2005EP1593683A2 Dihydro-2,3-Benzodiazepine derivatives
11/09/2005EP1593682A2 Derivatives of 4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides, process for their preparation and pharmaceutical compositions thereof
11/09/2005EP1593681A1 Tricyclic compound, process for producing the same, and use
11/09/2005EP1593680A1 Fused-ring pyridine derivative, process for producing the same, and use
11/09/2005EP1593679A1 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
11/09/2005EP1593676A1 8-Chloro-11-(4-(2'-hydroxyethyl)piperazin-1-yl)-dibenzo[b,f][1,4]oxazepine of atypical anti-psychotic activity and having a low affinity for the dopamine D2 receptor
11/09/2005EP1593667A1 Amine derivative
11/09/2005EP1593666A1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593394A2 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
11/09/2005EP1593393A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases
11/09/2005EP1593386A1 Use of galectin-2
11/09/2005EP1593381A1 Zinc oxide based formulation for preventing and treating diarrhea in farm animals
11/09/2005EP1593380A2 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1593378A1 Remedy for viral disease
11/09/2005EP1593373A1 Compositions comprising quaternary ammonium compounds
11/09/2005EP1593312A1 Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine
11/09/2005EP1593127A2 Radiation protection by gamma-tocotrienol
11/09/2005EP1592795A2 Oligomeric compounds for the modulation of ras expression
11/09/2005EP1592793A2 Oligomeric compounds for the modulation of survivin expression
11/09/2005EP1592780A2 Dyrks as modifiers of the apc and axin pathways and methods of use
11/09/2005EP1592707A2 Hmgb1 modulator binding domain
11/09/2005EP1592700A2 Avermectin- and avermectin monosaccharide derivatives substituted in the 4''- or 4'- position having pesticidal properties
11/09/2005EP1592694A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/09/2005EP1592693A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/09/2005EP1592691A1 Pyrazolo[1,5-a][1,3,5]triazine derivatives as cannabinoid receptor ligands
11/09/2005EP1592688A2 Polymorphic form b2 of ziprasidone base
11/09/2005EP1592685A1 BIPHENYL DERIVATIVES HAVING &bgr; sb 2 /sb ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/09/2005EP1592673A2 Novel substituted 2,3-benzodiazepine derivatives
11/09/2005EP1592670A1 Mercaptoimidazoles as ccr2 receptor antagonists
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1592668A1 Crystalline forms of pitavastatin calcium
11/09/2005EP1592667A2 New mono-acylated o-phenylendiamines derivatives
11/09/2005EP1592665A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/09/2005EP1592661A2 Cyclopropyl beta-amino acid derivatives
11/09/2005EP1592657A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
11/09/2005EP1592656A2 Medicinal compounds
11/09/2005EP1592464A2 Method of treating cognitive decline due to sleep deprivation and stress
11/09/2005EP1592453A1 Multiparticulate compositions of milnacipran for oral administration
11/09/2005EP1592451A1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound
11/09/2005EP1592448A1 Use of a porphyrin compound for the treatment of skin fungi
11/09/2005EP1592447A1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/09/2005EP1592446A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries
11/09/2005EP1592436A2 COMPOUNDS THAT BIND P2Y sb 2 /sb OR P2Y sb 1 /sb RECEPTORS
11/09/2005EP1592435A1 Ophthalmic formulation for the prevention and treatment of ocular conditions
11/09/2005EP1592432A2 Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer
11/09/2005EP1592431A1 Method of modulating il-6
11/09/2005EP1592430A2 Treatment of benign prostatic hyperplasia using energolytic agents
11/09/2005EP1592429A1 Method for inhibition of necrosis induced by neurotrophin
11/09/2005EP1592428A1 NEW CRYSTALLINE MODIFICATION OF 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N- 6-(1,1-DIOXO-1&lgr; sp 6 /sp -THIOMORPHOLIN-4-YL)-4(4-F LUORO-2-METHYL-PHENYL)-PYRIDIN-3-YL -N-METHYL-ISOBUTYRAMIDE
11/09/2005EP1592427A1 Multivitamin regimen for renal patients
11/09/2005EP1592426A1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/09/2005EP1592425A2 New arylpiperazinyl compounds
1 ... 4475 4476 4477 4478 4479 4480 4481 4482 4483 4484 4485 4486 4487 4488 4489 4490 4491 4492 4493 4494 4495 ... 7860